NO20026283L - Inhibitorer av kobberholdige aminosydaser - Google Patents

Inhibitorer av kobberholdige aminosydaser

Info

Publication number: NO20026283L
Authority: NO; Norway
Prior art keywords: acidases; inhibitors; copper; containing amino; amino
Prior art date: 2000-07-05

Application number

NO20026283A

Other languages

English (en)

Other versions

NO20026283D0 (no

Inventor

David John Smith

Markku Tapani Jalkanen

Ferenc Fueloep

Laszlo Lasar

Zsolt Szakonyi

Gabor Bernath

Original Assignee

Biotie Therapies Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-05

Filing date

2002-12-30

Publication date

2003-02-28

2002-12-30 Application filed by Biotie Therapies Corp filed Critical Biotie Therapies Corp

2002-12-30 Publication of NO20026283D0 publication Critical patent/NO20026283D0/no

2003-02-28 Publication of NO20026283L publication Critical patent/NO20026283L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Enzymes And Modification Thereof (AREA)
Other In-Based Heterocyclic Compounds (AREA)

NO20026283A 2000-07-05 2002-12-30 Inhibitorer av kobberholdige aminosydaser NO20026283L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21634100P	2000-07-05	2000-07-05
PCT/FI2001/000638 WO2002002090A2 (en)	2000-07-05	2001-07-04	Inhibitors of copper-containing amine oxidases

Publications (2)

Publication Number	Publication Date
NO20026283D0 NO20026283D0 (no)	2002-12-30
NO20026283L true NO20026283L (no)	2003-02-28

Family

ID=22806663

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20026282A NO20026282L (no)	2000-07-05	2002-12-30	Inhibitorer av kobberholdige aminoksydaser
NO20026283A NO20026283L (no)	2000-07-05	2002-12-30	Inhibitorer av kobberholdige aminosydaser

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO20026282A NO20026282L (no)	2000-07-05	2002-12-30	Inhibitorer av kobberholdige aminoksydaser

Country Status (14)

Country	Link
US (2)	US6624202B2 (no)
EP (2)	EP1313718A2 (no)
JP (2)	JP2004501962A (no)
CN (2)	CN1450998A (no)
AU (3)	AU2001282163B2 (no)
CA (2)	CA2414799A1 (no)
HU (2)	HUP0301336A3 (no)
IL (2)	IL153766A0 (no)
NO (2)	NO20026282L (no)
NZ (2)	NZ523464A (no)
PL (2)	PL360353A1 (no)
RU (2)	RU2003103286A (no)
WO (2)	WO2002002541A2 (no)
ZA (2)	ZA200300063B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001282163B2 (en)	2000-07-05	2004-12-09	Biotie Therapies Corp.	Inhibitors of copper-containing amine oxidases
US6982286B2 (en)	2001-07-12	2006-01-03	Biotie Therapies Corp.	Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
JP4650412B2 (ja)	2003-01-27	2011-03-16	アステラス製薬株式会社	チアゾール誘導体およびｖａｐ−１阻害剤としてのその使用
CA2520957C (en) *	2003-03-31	2013-08-06	Sucampo Ag	Method for treating vascular hyperpermeable disease
ES2335769T3 (es)	2003-05-26	2010-04-05	Biotie Therapies Corp.	Vap-1 cristalina y sus usos.
FI20031927A0 (fi) *	2003-12-31	2003-12-31	Faron Pharmaceuticals Oy	Terapeuttisesti vaikuttavia aineita ja niiden käyttö
FI20040136A0 (fi) *	2004-01-30	2004-01-30	Faron Pharmaceuticals Oy	Erityisesti diabeetikoille soveltuvia koostumuksia
US8119651B2 (en)	2004-01-30	2012-02-21	Biotie Therapies Corp.	Compositions useful especially for treatment or prevention of metabolic syndrome
PT1708711E (pt) *	2004-01-30	2010-06-01	Faron Pharmaceuticals Oy	Composições úteis em especial para o tratamento ou a prevenção da síndrome metabólica
FI20040270A0 (fi) *	2004-02-20	2004-02-20	Biotie Therapies Oyj	Kuparia sisältävien amiinioksidaasien imhibiittoreina käyttökelpoiset hydratsinoalkoholijohdannaiset
EP1786792B1 (en) *	2004-07-27	2009-04-08	Astellas Pharma Inc.	Thiazole derivatives having vap-1 inhibitory activity
WO2006028269A2 (en) *	2004-09-09	2006-03-16	Astellas Pharma Inc.	Thiazole derivatives having vap-1 ihibitory activity
JP4140630B2 (ja) *	2005-11-10	2008-08-27	Ｔｄｋ株式会社	磁気ヘッドアセンブリ及び磁気ヘッドアセンブリの製造方法
US20080058922A1 (en) *	2006-08-31	2008-03-06	Cardiac Pacemakers, Inc.	Methods and devices employing vap-1 inhibitors
US8372399B2 (en) *	2006-08-31	2013-02-12	Cardiac Pacemakers, Inc.	Bispecific antibodies and agents to enhance stem cell homing
US8636995B2 (en) *	2006-08-31	2014-01-28	Cardiac Pacemakers, Inc.	Methods and devices to regulate stem cell homing
FI20061156A0 (fi)	2006-12-27	2006-12-27	Elina Kivi	Uusia peptidejä
US20090170770A1 (en) *	2007-11-06	2009-07-02	Ali Hafezi-Moghadam	Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap 1) inhibitor
AU2008327615B2 (en)	2007-11-21	2014-08-21	Pharmaxis Ltd.	Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor
TWI437986B (zh)	2008-01-31	2014-05-21	R Tech Ueno Ltd	噻唑衍生物及使用該衍生物作為ｖａｐ－１抑制劑之用途
TWI490214B (zh)	2008-05-30	2015-07-01	艾德克上野股份有限公司	苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途
US8906642B2 (en)	2008-09-03	2014-12-09	Universitat Autonoma De Barcelona	Methods and compositions for the treatment and diagnosis of haemorrhagic conversion
RU2400233C1 (ru)	2009-07-07	2010-09-27	Общество с ограниченной ответственностью "Вирфарм"	Способ лечения заболеваний печени различного генеза
UA112154C2 (uk)	2009-09-08	2016-08-10	Біоті Терапіс Корп.	Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів
RU2012114846A (ru)	2009-09-16	2013-10-27	Астеллас Фарма Инк.	Соединение глицина
RU2010145439A (ru) *	2010-11-08	2012-05-20	Виктор Вениаминович Тец (RU)	Средство для лечения поражений печени, вызванных воздействием химических или биологических агентов
FI20115234A0 (fi)	2011-03-08	2011-03-08	Biotie Therapies Corp	Uusia pyridatsinoni- ja pyridoniyhdisteitä
EA025839B1 (ru)	2011-03-15	2017-02-28	Астеллас Фарма Инк.	Гуанидиновые соединения, полезные для предотвращения и/или лечения диабетической нефропатии или диабетического отека желтого пятна
AU2014279863A1 (en)	2013-06-12	2016-01-28	Proximagen Limited	New therapeutic uses of enzyme inhibitors
US9790193B2 (en)	2014-04-15	2017-10-17	Pécsi Tudományegyetem	Semicarbazide-sensitive amine oxidase inhibitors for use as analgesics in traumatic neuropathy and neurogenic inflammation
WO2015189534A1 (en)	2014-06-12	2015-12-17	Proximagen Limited	Vap-1 inhibitors for treating muscular dystrophy
RU2595868C1 (ru)	2015-03-27	2016-08-27	Виктор Вениаминович Тец	Лекарственное средство с гепатопротекторной активностью
JP2018076236A (ja)	2015-06-05	2018-05-17	株式会社アールテック・ウエノ	がんを処置するための医薬組成物
EP3777846A1 (en)	2015-12-07	2021-02-17	BenevolentAI Cambridge Limited	Vap-1 inhibitors for treating pain
CN109810041B (zh) *	2017-11-21	2023-08-15	药捷安康(南京)科技股份有限公司	卤代烯丙基胺类ssao/vap-1抑制剂及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3377345A (en) *	1966-09-23	1968-04-09	Dow Chemical Co	Substituted 3, 4, 5, 6-tetrahydro-2h-1, 3, 4-oxadiazin-2-one compounds and method ofpreparation thereof
US3486916A (en)	1966-12-22	1969-12-30	William A Cordon	Cement mixes and the production of articles therefrom
SE320311B (no)	1968-07-15	1970-02-02	Mo Och Domsjoe Ab
WO1993023023A1 (en) *	1992-05-15	1993-11-25	University Of Saskatchewan	Method for preventing endothelium damage in mammals and for alleviating pain associated with gout and arthritis
US5413634A (en)	1993-08-06	1995-05-09	Arco Chemical Technology, L.P.	Cement composition
CA2117585C (en)	1993-09-14	2001-06-05	Edward T. Shawl	Cement composition
WO1996006058A1 (en)	1994-08-25	1996-02-29	W.R. Grace & Co.-Conn.	Shrinkage reduction cement composition
US5618344A (en)	1995-03-06	1997-04-08	W. R. Grace & Co.-Conn.	Cement composition
US5556460A (en)	1995-09-18	1996-09-17	W.R. Grace & Co.-Conn.	Drying shrinkage cement admixture
US5603760A (en)	1995-09-18	1997-02-18	W. R. Grace & Co.-Conn.	Cement admixture capable of inhibiting drying shrinkage and method of using same
AU2001282163B2 (en)	2000-07-05	2004-12-09	Biotie Therapies Corp.	Inhibitors of copper-containing amine oxidases

2001
- 2001-07-04 AU AU2001282163A patent/AU2001282163B2/en not_active Ceased
- 2001-07-04 PL PL36035301A patent/PL360353A1/xx not_active Application Discontinuation
- 2001-07-04 WO PCT/FI2001/000637 patent/WO2002002541A2/en not_active Application Discontinuation
- 2001-07-04 NZ NZ523464A patent/NZ523464A/en unknown
- 2001-07-04 PL PL36037401A patent/PL360374A1/xx not_active Application Discontinuation
- 2001-07-04 EP EP01960764A patent/EP1313718A2/en not_active Withdrawn
- 2001-07-04 JP JP2002506712A patent/JP2004501962A/ja not_active Withdrawn
- 2001-07-04 JP JP2002507795A patent/JP2004502682A/ja not_active Withdrawn
- 2001-07-04 IL IL15376601A patent/IL153766A0/xx unknown
- 2001-07-04 WO PCT/FI2001/000638 patent/WO2002002090A2/en not_active Application Discontinuation
- 2001-07-04 HU HU0301336A patent/HUP0301336A3/hu unknown
- 2001-07-04 RU RU2003103286/15A patent/RU2003103286A/ru not_active Application Discontinuation
- 2001-07-04 IL IL15376701A patent/IL153767A0/xx unknown
- 2001-07-04 CA CA002414799A patent/CA2414799A1/en not_active Abandoned
- 2001-07-04 NZ NZ523463A patent/NZ523463A/en unknown
- 2001-07-04 CN CN01815102A patent/CN1450998A/zh active Pending
- 2001-07-04 AU AU2001282162A patent/AU2001282162A1/en not_active Abandoned
- 2001-07-04 RU RU2003103291/04A patent/RU2003103291A/ru not_active Application Discontinuation
- 2001-07-04 HU HU0301625A patent/HUP0301625A3/hu unknown
- 2001-07-04 EP EP01960763A patent/EP1301495A2/en not_active Withdrawn
- 2001-07-04 AU AU8216301A patent/AU8216301A/xx active Pending
- 2001-07-04 CA CA002414807A patent/CA2414807A1/en not_active Abandoned
- 2001-07-04 CN CN01815101A patent/CN1450997A/zh active Pending
- 2001-07-05 US US09/898,003 patent/US6624202B2/en not_active Expired - Fee Related
2002
- 2002-12-30 NO NO20026282A patent/NO20026282L/no not_active Application Discontinuation
- 2002-12-30 NO NO20026283A patent/NO20026283L/no not_active Application Discontinuation
2003
- 2003-01-03 ZA ZA200300063A patent/ZA200300063B/en unknown
- 2003-01-03 ZA ZA200300064A patent/ZA200300064B/en unknown
- 2003-07-21 US US10/622,581 patent/US20040106654A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU8216301A (en)	2002-01-14
CA2414807A1 (en)	2002-01-10
NO20026282D0 (no)	2002-12-30
NZ523463A (en)	2004-06-25
CN1450997A (zh)	2003-10-22
WO2002002090A2 (en)	2002-01-10
IL153767A0 (en)	2003-07-06
JP2004501962A (ja)	2004-01-22
EP1301495A2 (en)	2003-04-16
WO2002002541A2 (en)	2002-01-10
AU2001282163B2 (en)	2004-12-09
HUP0301625A2 (hu)	2003-11-28
RU2003103291A (ru)	2005-01-27
ZA200300063B (en)	2003-07-22
PL360374A1 (en)	2004-09-06
NO20026283D0 (no)	2002-12-30
EP1313718A2 (en)	2003-05-28
CA2414799A1 (en)	2002-01-10
IL153766A0 (en)	2003-07-06
NO20026282L (no)	2003-03-03
US20020173521A1 (en)	2002-11-21
JP2004502682A (ja)	2004-01-29
HUP0301336A3 (en)	2005-04-28
US20040106654A1 (en)	2004-06-03
WO2002002541A3 (en)	2002-04-18
HUP0301625A3 (en)	2005-04-28
NZ523464A (en)	2003-10-31
WO2002002090A3 (en)	2002-05-16
ZA200300064B (en)	2003-07-22
RU2003103286A (ru)	2004-08-20
PL360353A1 (en)	2004-09-06
CN1450998A (zh)	2003-10-22
US6624202B2 (en)	2003-09-23
AU2001282162A1 (en)	2002-01-14
HUP0301336A2 (hu)	2003-08-28

Publication	Publication Date	Title
NO20026283L (no)	2003-02-28	Inhibitorer av kobberholdige aminosydaser
AR028253A1 (es)	2003-04-30	Inhibidores de la glucogeno fosforilasa
DE60234125D1 (de)	2009-12-03	E inhibitoren
PT1370553E (pt)	2006-09-29	Inibidores de rhoquinase
CY2012007I1 (el)	2014-07-02	Πεπτιδομιμητικοι αναστολεις πρωτεασης
CY2015028I1 (el)	2016-07-27	Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
NO20034045D0 (no)	2003-09-12	Metallproteinase-inhibitorer
ATE512949T1 (de)	2011-07-15	Reninhemmer
NO20023780D0 (no)	2002-08-09	Dipeptid nitril katepsin K inhibitorer
DK1560584T3 (da)	2009-05-18	Fab I inhibitorer
NO20034032D0 (no)	2003-09-11	Metallproteinase-inhibitorer
DE60035039D1 (de)	2007-07-12	Renin inhibitoren
DK1272488T3 (da)	2006-07-17	Tri-aryl-substitueret ethan-PDE4-inhibitorer
AR028261A1 (es)	2003-04-30	Inhibidores triciclicos de la proteina quinasa
BR0207810A (pt)	2008-04-15	inibidores de deformilase de peptìdeo
NO20025786L (no)	2003-02-12	Protaseinhibitorer
NO20025281D0 (no)	2002-11-04	Peptid-deformylase-inhibitorer
NO20025005L (no)	2002-12-06	Proteaseinhibitorer
DK1130214T3 (da)	2005-08-29	Korrosionsinhibitorer
NO20025282D0 (no)	2002-11-04	Peptid-deformylase-inhibitorer
DE60132468D1 (de)	2008-03-06	Alen-lanosterol zyklase inhibitoren
NO20032328L (no)	2003-07-02	Proteaseinhibitorer
FI20002015A0 (fi)	2000-09-13	Kuparia sisältävien amiinioksidaasien inhibiittorit
SE0004239D0 (sv)	2000-11-17	New use of an inhibitor

Legal Events

Date	Code	Title	Description
2006-02-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application